List of Tables
Table 1. Global Hypertriglyceridemia Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of BioE-1115
Table 3. Key Players of CAT-2003
Table 4. Key Players of CDX-085
Table 5. Key Players of AEM-2814
Table 6. Key Players of ALN-AC3
Table 7. Key Players of Others
Table 8. Global Hypertriglyceridemia Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Hypertriglyceridemia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Hypertriglyceridemia Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Hypertriglyceridemia Treatment Market Share by Region (2019-2024)
Table 12. Global Hypertriglyceridemia Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Hypertriglyceridemia Treatment Market Share by Region (2025-2030)
Table 14. Hypertriglyceridemia Treatment Market Trends
Table 15. Hypertriglyceridemia Treatment Market Drivers
Table 16. Hypertriglyceridemia Treatment Market Challenges
Table 17. Hypertriglyceridemia Treatment Market Restraints
Table 18. Global Hypertriglyceridemia Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Hypertriglyceridemia Treatment Market Share by Players (2019-2024)
Table 20. Global Top Hypertriglyceridemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertriglyceridemia Treatment as of 2023)
Table 21. Ranking of Global Top Hypertriglyceridemia Treatment Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Hypertriglyceridemia Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hypertriglyceridemia Treatment Product Solution and Service
Table 25. Date of Enter into Hypertriglyceridemia Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hypertriglyceridemia Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Hypertriglyceridemia Treatment Revenue Market Share by Type (2019-2024)
Table 29. Global Hypertriglyceridemia Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Hypertriglyceridemia Treatment Revenue Market Share by Type (2025-2030)
Table 31. Global Hypertriglyceridemia Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Hypertriglyceridemia Treatment Revenue Market Share by Application (2019-2024)
Table 33. Global Hypertriglyceridemia Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Hypertriglyceridemia Treatment Revenue Market Share by Application (2025-2030)
Table 35. North America Hypertriglyceridemia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Hypertriglyceridemia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Hypertriglyceridemia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Hypertriglyceridemia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Hypertriglyceridemia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Hypertriglyceridemia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Hypertriglyceridemia Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Hypertriglyceridemia Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Hypertriglyceridemia Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Hypertriglyceridemia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Hypertriglyceridemia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Hypertriglyceridemia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Hypertriglyceridemia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Hypertriglyceridemia Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hypertriglyceridemia Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 50. Acasti Pharma Inc Company Detail
Table 51. Acasti Pharma Inc Business Overview
Table 52. Acasti Pharma Inc Hypertriglyceridemia Treatment Product
Table 53. Acasti Pharma Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 54. Acasti Pharma Inc Recent Development
Table 55. Akcea Therapeutics Inc Company Detail
Table 56. Akcea Therapeutics Inc Business Overview
Table 57. Akcea Therapeutics Inc Hypertriglyceridemia Treatment Product
Table 58. Akcea Therapeutics Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 59. Akcea Therapeutics Inc Recent Development
Table 60. Allergan Plc Company Detail
Table 61. Allergan Plc Business Overview
Table 62. Allergan Plc Hypertriglyceridemia Treatment Product
Table 63. Allergan Plc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 64. Allergan Plc Recent Development
Table 65. Alnylam Pharmaceuticals Inc Company Detail
Table 66. Alnylam Pharmaceuticals Inc Business Overview
Table 67. Alnylam Pharmaceuticals Inc Hypertriglyceridemia Treatment Product
Table 68. Alnylam Pharmaceuticals Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 69. Alnylam Pharmaceuticals Inc Recent Development
Table 70. Arisaph Pharmaceuticals Inc Company Detail
Table 71. Arisaph Pharmaceuticals Inc Business Overview
Table 72. Arisaph Pharmaceuticals Inc Hypertriglyceridemia Treatment Product
Table 73. Arisaph Pharmaceuticals Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 74. Arisaph Pharmaceuticals Inc Recent Development
Table 75. AstraZeneca Plc Company Detail
Table 76. AstraZeneca Plc Business Overview
Table 77. AstraZeneca Plc Hypertriglyceridemia Treatment Product
Table 78. AstraZeneca Plc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 79. AstraZeneca Plc Recent Development
Table 80. BASF SE Company Detail
Table 81. BASF SE Business Overview
Table 82. BASF SE Hypertriglyceridemia Treatment Product
Table 83. BASF SE Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 84. BASF SE Recent Development
Table 85. Cardax Inc Company Detail
Table 86. Cardax Inc Business Overview
Table 87. Cardax Inc Hypertriglyceridemia Treatment Product
Table 88. Cardax Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 89. Cardax Inc Recent Development
Table 90. Catabasis Pharmaceuticals Inc Company Detail
Table 91. Catabasis Pharmaceuticals Inc Business Overview
Table 92. Catabasis Pharmaceuticals Inc Hypertriglyceridemia Treatment Product
Table 93. Catabasis Pharmaceuticals Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 94. Catabasis Pharmaceuticals Inc Recent Development
Table 95. Celon Pharma SA Company Detail
Table 96. Celon Pharma SA Business Overview
Table 97. Celon Pharma SA Hypertriglyceridemia Treatment Product
Table 98. Celon Pharma SA Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 99. Celon Pharma SA Recent Development
Table 100. CymaBay Therapeutics Inc Company Detail
Table 101. CymaBay Therapeutics Inc Business Overview
Table 102. CymaBay Therapeutics Inc Hypertriglyceridemia Treatment Product
Table 103. CymaBay Therapeutics Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 104. CymaBay Therapeutics Inc Recent Development
Table 105. Gemphire Therapeutics Inc Company Detail
Table 106. Gemphire Therapeutics Inc Business Overview
Table 107. Gemphire Therapeutics Inc Hypertriglyceridemia Treatment Product
Table 108. Gemphire Therapeutics Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 109. Gemphire Therapeutics Inc Recent Development
Table 110. Jeil Pharmaceutical Co Ltd Company Detail
Table 111. Jeil Pharmaceutical Co Ltd Business Overview
Table 112. Jeil Pharmaceutical Co Ltd Hypertriglyceridemia Treatment Product
Table 113. Jeil Pharmaceutical Co Ltd Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 114. Jeil Pharmaceutical Co Ltd Recent Development
Table 115. Kyorin Pharmaceutical Co Ltd Company Detail
Table 116. Kyorin Pharmaceutical Co Ltd Business Overview
Table 117. Kyorin Pharmaceutical Co Ltd Hypertriglyceridemia Treatment Product
Table 118. Kyorin Pharmaceutical Co Ltd Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 119. Kyorin Pharmaceutical Co Ltd Recent Development
Table 120. LipimetiX Development Inc Company Detail
Table 121. LipimetiX Development Inc Business Overview
Table 122. LipimetiX Development Inc Hypertriglyceridemia Treatment Product
Table 123. LipimetiX Development Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 124. LipimetiX Development Inc Recent Development
Table 125. Matinas BioPharma Holdings Inc Company Detail
Table 126. Matinas BioPharma Holdings Inc Business Overview
Table 127. Matinas BioPharma Holdings Inc Hypertriglyceridemia Treatment Product
Table 128. Matinas BioPharma Holdings Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 129. Matinas BioPharma Holdings Inc Recent Development
Table 130. Sancilio & Company Inc Company Detail
Table 131. Sancilio & Company Inc Business Overview
Table 132. Sancilio & Company Inc Hypertriglyceridemia Treatment Product
Table 133. Sancilio & Company Inc Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 134. Sancilio & Company Inc Recent Development
Table 135. Zydus Cadila Healthcare Ltd Company Detail
Table 136. Zydus Cadila Healthcare Ltd Business Overview
Table 137. Zydus Cadila Healthcare Ltd Hypertriglyceridemia Treatment Product
Table 138. Zydus Cadila Healthcare Ltd Revenue in Hypertriglyceridemia Treatment Business (2019-2024) & (US$ Million)
Table 139. Zydus Cadila Healthcare Ltd Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypertriglyceridemia Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hypertriglyceridemia Treatment Market Share by Type: 2023 VS 2030
Figure 3. BioE-1115 Features
Figure 4. CAT-2003 Features
Figure 5. CDX-085 Features
Figure 6. AEM-2814 Features
Figure 7. ALN-AC3 Features
Figure 8. Others Features
Figure 9. Global Hypertriglyceridemia Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Hypertriglyceridemia Treatment Market Share by Application: 2023 VS 2030
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Hypertriglyceridemia Treatment Report Years Considered
Figure 15. Global Hypertriglyceridemia Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Hypertriglyceridemia Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Hypertriglyceridemia Treatment Market Share by Region: 2023 VS 2030
Figure 18. Global Hypertriglyceridemia Treatment Market Share by Players in 2023
Figure 19. Global Top Hypertriglyceridemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertriglyceridemia Treatment as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Hypertriglyceridemia Treatment Revenue in 2023
Figure 21. North America Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Hypertriglyceridemia Treatment Market Share by Country (2019-2030)
Figure 23. United States Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Hypertriglyceridemia Treatment Market Share by Country (2019-2030)
Figure 27. Germany Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Hypertriglyceridemia Treatment Market Share by Region (2019-2030)
Figure 35. China Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Hypertriglyceridemia Treatment Market Share by Country (2019-2030)
Figure 43. Mexico Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Hypertriglyceridemia Treatment Market Share by Country (2019-2030)
Figure 47. Turkey Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Hypertriglyceridemia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Acasti Pharma Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 50. Akcea Therapeutics Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 51. Allergan Plc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 52. Alnylam Pharmaceuticals Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 53. Arisaph Pharmaceuticals Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 54. AstraZeneca Plc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 55. BASF SE Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 56. Cardax Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 57. Catabasis Pharmaceuticals Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 58. Celon Pharma SA Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 59. CymaBay Therapeutics Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 60. Gemphire Therapeutics Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 61. Jeil Pharmaceutical Co Ltd Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 62. Kyorin Pharmaceutical Co Ltd Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 63. LipimetiX Development Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 64. Matinas BioPharma Holdings Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 65. Sancilio & Company Inc Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 66. Zydus Cadila Healthcare Ltd Revenue Growth Rate in Hypertriglyceridemia Treatment Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed